CLXT

Calyxt Inc
0.3626
0.0401 (12.43%)

Period:

Draw Mode:

Volume 184,495
Bid Price 0.3626
Ask Price 0.365
News -
Day High 0.37

Low
0.125

52 Week Range

High
1.33

Day Low 0.3066
Company Name Stock Ticker Symbol Market Type
Calyxt Inc CLXT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0401 12.43% 0.3626 13:09:39
Open Price Low Price High Price Close Price Prev Close
0.3243 0.3066 0.37 0.3225
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
187 184,495 $ 0.3348443 $ 61,777 - 0.125 - 1.33
Last Trade Time Type Quantity Stock Price Currency
13:08:53 3 $ 0.365 USD

Calyxt Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 17.90M 49.38M 25.18M $ 157.00k $ -139.45k -0.37 -0.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -187.50k 4.30%

more financials information »

Calyxt News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CLXT Message Board. Create One! See More Posts on CLXT Message Board See More Message Board Posts

Historical CLXT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.31570.370.2850.3331917137,6410.046914.86%
1 Month0.370.4580.25180.3747261222,481-0.0074-2.0%
3 Months0.1350.50770.1320.33501372,049,7580.2276168.59%
6 Months0.21660.50770.1250.30483591,164,6010.14667.41%
1 Year1.181.330.1250.34572961,078,150-0.8174-69.27%
3 Years3.2612.430.1251.51482,774-2.90-88.88%
5 Years17.5422.320.1252.59328,713-17.18-97.93%

Calyxt Description

Calyxt Inc is a plant-based synthetic biology company. The company leverages its proprietary PlantSpring technology platform to engineer plant metabolism to produce high value plant-based chemistries for use in customers materials and products.. The company's diversified offerings are delivered through its proprietary BioFactory production system. The Company operates in the development and commercialization of products derived from plant cells.